These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 35259919)
41. Minireview: Epigenomic Plasticity and Vulnerability to EDC Exposures. Walker CL Mol Endocrinol; 2016 Aug; 30(8):848-55. PubMed ID: 27355193 [TBL] [Abstract][Full Text] [Related]
42. Ethical implications of epigenetics in the era of personalized medicine. Santaló J; Berdasco M Clin Epigenetics; 2022 Mar; 14(1):44. PubMed ID: 35337378 [TBL] [Abstract][Full Text] [Related]
43. Minireview: Epigenetics of obesity and diabetes in humans. Slomko H; Heo HJ; Einstein FH Endocrinology; 2012 Mar; 153(3):1025-30. PubMed ID: 22253427 [TBL] [Abstract][Full Text] [Related]
44. Interview with Stephen B Baylin. Baylin SB Epigenomics; 2015; 7(6):881-3. PubMed ID: 26418030 [TBL] [Abstract][Full Text] [Related]
45. Data science using the human epigenome for predicting multifactorial diseases and symptoms. Nishitani S; Smith AK; Tomoda A; Fujisawa TX Epigenomics; 2024 Mar; 16(5):273-276. PubMed ID: 38312014 [TBL] [Abstract][Full Text] [Related]
46. The Minderoo-Monaco Commission on Plastics and Human Health. Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097 [TBL] [Abstract][Full Text] [Related]
47. Increased understanding of the impact of environmental exposures on the epigenome. O'Hagan HM; Tang WY Environ Mol Mutagen; 2014 Apr; 55(3):151-4. PubMed ID: 24339126 [No Abstract] [Full Text] [Related]
48. Drugging the epigenome in the age of precision medicine. Feehley T; O'Donnell CW; Mendlein J; Karande M; McCauley T Clin Epigenetics; 2023 Jan; 15(1):6. PubMed ID: 36631803 [TBL] [Abstract][Full Text] [Related]
49. Public knowledge and opinion of epigenetics and epigenetic concepts. Lynch F; Lewis S; Macciocca I; Craig JM J Dev Orig Health Dis; 2022 Aug; 13(4):431-440. PubMed ID: 34503601 [TBL] [Abstract][Full Text] [Related]
52. Dietary Modulation of the Epigenome. Ideraabdullah FY; Zeisel SH Physiol Rev; 2018 Apr; 98(2):667-695. PubMed ID: 29442595 [TBL] [Abstract][Full Text] [Related]
53. The epigenome as a target for heritable environmental disruptions of cellular function. McCarrey JR Mol Cell Endocrinol; 2012 May; 354(1-2):9-15. PubMed ID: 21970811 [TBL] [Abstract][Full Text] [Related]
55. From promises to practical strategies in epigenetic epidemiology. Mill J; Heijmans BT Nat Rev Genet; 2013 Aug; 14(8):585-94. PubMed ID: 23817309 [TBL] [Abstract][Full Text] [Related]
56. Interview: commercial translation of cell-based therapies and regenerative medicine: learning by experience. Interview by Emily Culme-Seymour. Haseltine WA Regen Med; 2011 Jul; 6(4):431-5. PubMed ID: 21749201 [TBL] [Abstract][Full Text] [Related]
57. Life as an early career researcher: interview with Catherine Martel. Martel C Future Sci OA; 2016 Mar; 2(1):FSO108. PubMed ID: 28031952 [No Abstract] [Full Text] [Related]
58. Early life precursors, epigenetics, and the development of food allergy. Hong X; Wang X Semin Immunopathol; 2012 Sep; 34(5):655-69. PubMed ID: 22777545 [TBL] [Abstract][Full Text] [Related]
59. Linking epidemiology to epigenomics--where are we today? Ulrich CM; Grady WM Cancer Prev Res (Phila); 2010 Dec; 3(12):1505-8. PubMed ID: 21149325 [TBL] [Abstract][Full Text] [Related]